To confirm whether Nintedanib treatment (5 and 10 μM) could also affect the expression of VEGF receptors in human PCa cell lines, we analyzed the expression of both VEGFR-1 and R-2 in cell lysates. The gene discussed is FLT1; the disease is posterior cortical atrophy.